\-\ Texto\\:\\ \ \(0\)\
\-\ thyroid\\ gland\\-\\ non\\-tender\\,\\ estimated\\ to\\ be\\ approximately\\ 25\\-30\\ grams\\ in\\ size\\.\\ \\ the\\ contour\\ of\\ the\\ thyroid\\ is\\ irregular\\.\\ \\ no\\ discrete\\ nodules\\ are\\ palpable\\.\\ \\ no\\ cervical\\ lymphadenopathy\\ is\\ appreciated\\.tsh\\-\\ \\<0\\.08\\ \\(ref\\ 0\\.49\\-4\\.67\\)ft4\\-\\ 1\\.30\\ \\(ref\\ 0\\.71\\-1\\.85\\)\ \(0\)\
\-\ treatment\\ options\\:\\ i\\-131\\ ablation\\,\\ thioamides\\ \\(methimazole\\ or\\ propylthiouracil\\,\\ b\\-blockers\\ like\\ propanolol\\,\\ surgery\\ \\(thyroidectomy\\)\\,\\ or\\ close\\ clinical\\ follow\\-up\\ without\\ medical\\ or\\ surgical\\ interventionfollow\\-up\\:\\ nm\\ uptake\\ scans\\ can\\ be\\ performed\\ after\\ a\\ series\\ of\\ hyperthyroid\\ treatment\\ as\\ above\\ to\\ assess\\ effectiveness\\ of\\ treatment\\.\\ \\ if\\ concern\\ is\\ for\\ cold\\ nodules\\,\\ fna\\ can\\ be\\ performed\\ to\\ rule\\ out\\ malignancy\\.\ \(0\)\
\-\ i\\-123\\ 24\\-hour\\ thyroid\\ uptake\\ scan\\ was\\ performed\\.\\ \\ the\\ thyroid\\ gland\\ appears\\ symmetrical\\,\\ in\\ usual\\ shape\\ and\\ location\\.\\ \\ there\\ are\\ four\\ foci\\ of\\ increased\\ radiotracer\\ concentration\\ within\\ the\\ gland\\;\\ one\\ at\\ the\\ level\\ of\\ the\\ isthmus\\ on\\ the\\ right\\,\\ one\\ small\\ focus\\ at\\ the\\ junction\\ of\\ the\\ middle\\ and\\ lower\\ thirds\\ of\\ the\\ right\\ lobe\\,\\ one\\ in\\ the\\ upper\\ left\\ lobe\\ and\\ one\\ in\\ the\\ mid\\-lower\\ half\\ of\\ the\\ left\\ lobe\\.\\ \\ there\\ are\\ no\\ photopenic\\ areas\\ identified\\.\\ \\ the\\ thyroid\\-to\\-background\\ ratio\\ appears\\ normal\\ to\\ increased\\.radioiodine\\ uptake\\:\\ 4\\ hours\\-\\ 6\\%\\ \\(ref\\ 2\\-12\\%\\)\\;\\ 24\\ hours\\-\\ 16\\%\\ \\(ref\\ 12\\-30\\%\\)\ \(0\)\
\-\ toxic\\ multinodular\\ goiter\ \(1\)\
\-\ toxic\\ multinodular\\ goiter\ \(1\)\
\-\ hashimoto\\â\\€\\™s\\ thyroiditis\ \(0\)\
\-\ subacute\\ thyroiditis\ \(5\)\
\-\ iodine\\ deficiency\ \(0\)\
\-\ excessive\\ thyroid\\ hormone\\ ingestion\ \(0\)\
\-\ grave\\â\\€\\™s\\ disease\ \(0\)\
\-\ 48\\ yo\\ woman\\ followed\\ in\\ the\\ internal\\ medicine\\ clinic\\ for\\ abnormal\\ thyroid\\ function\\ tests\\,\\ she\\ is\\ clinically\\ euthyroid\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ thyroid\\:\\ 0\\.3567108529104635\ \(0\)\
\-\ ref\\:\\ 0\\.3174845683782943\ \(0\)\
\-\ the\\:\\ 0\\.19407733923110074\ \(0\)\
\-\ multinodular\\:\\ 0\\.15874228418914715\ \(0\)\
\-\ gland\\:\\ 0\\.15802322586846396\ \(0\)\
\-\ uptake\\:\\ 0\\.14958094194497695\ \(0\)\
\-\ one\\:\\ 0\\.14850220043347126\ \(0\)\
\-\ goiter\\:\\ 0\\.14582947585332293\ \(0\)\
\-\ thyroiditis\\:\\ 0\\.1436626507265928\ \(0\)\
\-\ toxic\\:\\ 0\\.1324664655507337\ \(0\)\
\-\ performed\\:\\ 0\\.11508364672192369\ \(0\)\
\-\ lobe\\:\\ 0\\.1124168695023844\ \(0\)\
\-\ thioamides\\:\\ 0\\.1036977625324373\ \(0\)\
\-\ propylthiouracil\\:\\ 0\\.1036977625324373\ \(0\)\
\-\ propanolol\\:\\ 0\\.1036977625324373\ \(0\)\
\-\ nodules\\:\\ 0\\.10304308462122401\ \(0\)\
\-\ of\\:\\ 0\\.10151560044095756\ \(0\)\
\-\ euthyroid\\:\\ 0\\.09581860035667096\ \(0\)\
\-\ appears\\:\\ 0\\.0949689210487216\ \(0\)\
\-\ methimazole\\:\\ 0\\.09328207668811796\ \(0\)\
\-\ treatment\\:\\ 0\\.09266420698175228\ \(0\)\
\-\ 24\\:\\ 0\\.09194327286816822\ \(0\)\
\-\ hyperthyroid\\:\\ 0\\.09120958594674715\ \(0\)\
\-\ effectiveness\\:\\ 0\\.08540291451235162\ \(0\)\
\-\ grams\\:\\ 0\\.08333042377098082\ \(0\)\
\-\ nm\\:\\ 0\\.08333042377098082\ \(0\)\
\-\ grave\\:\\ 0\\.08242056004732291\ \(0\)\
\-\ isthmus\\:\\ 0\\.08157815781660958\ \(0\)\
\-\ to\\:\\ 0\\.08105287019163267\ \(0\)\
\-\ hashimoto\\:\\ 0\\.0807939001024278\ \(0\)\
\-\ in\\:\\ 0\\.0806539281324157\ \(0\)\
\-\ be\\:\\ 0\\.07891240191728717\ \(0\)\
\-\ photopenic\\:\\ 0\\.078721409361057\ \(0\)\
\-\ concentration\\:\\ 0\\.07752375233658529\ \(0\)\
\-\ thyroidectomy\\:\\ 0\\.07696914340668577\ \(0\)\
\-\ fna\\:\\ 0\\.07593504644430366\ \(0\)\
\-\ thirds\\:\\ 0\\.07545126159521448\ \(0\)\
\-\ are\\:\\ 0\\.07381468711720308\ \(0\)\
\-\ symmetrical\\:\\ 0\\.07330010460080277\ \(0\)\
\-\ iodine\\:\\ 0\\.07149197991880725\ \(0\)\
\-\ is\\:\\ 0\\.07103057146399436\ \(0\)\
\-\ ablation\\:\\ 0\\.07084224718529067\ \(0\)\
\-\ ingestion\\:\\ 0\\.07022765274311547\ \(0\)\
\-\ increased\\:\\ 0\\.0701278119192227\ \(0\)\
\-\ excessive\\:\\ 0\\.06993238346163276\ \(0\)\
\-\ cold\\:\\ 0\\.06908998123091943\ \(0\)\
\-\ can\\:\\ 0\\.06805490032347357\ \(0\)\
\-\ or\\:\\ 0\\.06767297239557152\ \(0\)\
\-\ estimated\\:\\ 0\\.06733771527654821\ \(0\)\
\-\ usual\\:\\ 0\\.06733771527654821\ \(0\)\
\-\ discrete\\:\\ 0\\.06710806649226593\ \(0\)\
\-\ lower\\:\\ 0\\.06626948904326897\ \(0\)\
\-\ hormone\\:\\ 0\\.06602465392890086\ \(0\)\
\-\ ratio\\:\\ 0\\.06503557575089512\ \(0\)\
\-\ deficiency\\:\\ 0\\.0634468698586135\ \(0\)\
\-\ no\\:\\ 0\\.06325842769307435\ \(0\)\
\-\ tests\\:\\ 0\\.06205322128586643\ \(0\)\
\-\ shape\\:\\ 0\\.06148474142294941\ \(0\)\
\-\ half\\:\\ 0\\.06107629407448789\ \(0\)\
\-\ subacute\\:\\ 0\\.060682015421687545\ \(0\)\
\-\ assess\\:\\ 0\\.05993225615036551\ \(0\)\
\-\ series\\:\\ 0\\.05945855310078187\ \(0\)\
\-\ concern\\:\\ 0\\.05945855310078187\ \(0\)\
\-\ close\\:\\ 0\\.05867429538660008\ \(0\)\
\-\ options\\:\\ 0\\.05845981301977427\ \(0\)\
\-\ contour\\:\\ 0\\.058354070599600516\ \(0\)\
\-\ medicine\\:\\ 0\\.057156413575128795\ \(0\)\
\-\ radiotracer\\:\\ 0\\.056601804645229285\ \(0\)\
\-\ scans\\:\\ 0\\.05642278947783931\ \(0\)\
\-\ 48\\:\\ 0\\.05615944422832485\ \(0\)\
\-\ focus\\:\\ 0\\.05492713099348034\ \(0\)\
\-\ clinic\\:\\ 0\\.05461988990657578\ \(0\)\
\-\ clinically\\:\\ 0\\.053886265809286286\ \(0\)\
\-\ foci\\:\\ 0\\.052998283186123665\ \(0\)\
\-\ four\\:\\ 0\\.05254739916520497\ \(0\)\
\-\ function\\:\\ 0\\.052484422670620944\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.05242179315572886\ \(0\)\
\-\ junction\\:\\ 0\\.051932804723029795\ \(0\)\
\-\ there\\:\\ 0\\.05160150224994503\ \(0\)\
\-\ rule\\:\\ 0\\.05146398660183991\ \(0\)\
\-\ 16\\:\\ 0\\.0505276566771752\ \(0\)\
\-\ irregular\\:\\ 0\\.050061509113544254\ \(0\)\
\-\ at\\:\\ 0\\.04898389715444825\ \(0\)\
\-\ malignancy\\:\\ 0\\.04854362730207298\ \(0\)\
\-\ like\\:\\ 0\\.048193838835997385\ \(0\)\
\-\ above\\:\\ 0\\.046778681783422926\ \(0\)\
\-\ cervical\\:\\ 0\\.04644157288162616\ \(0\)\
\-\ middle\\:\\ 0\\.04636799833223023\ \(0\)\
\-\ identified\\:\\ 0\\.04597163643408411\ \(0\)\
\-\ palpable\\:\\ 0\\.04555444362194109\ \(0\)\
\-\ location\\:\\ 0\\.04515202183852782\ \(0\)\
\-\ left\\:\\ 0\\.04423859044881281\ \(0\)\
\-\ areas\\:\\ 0\\.04402376808014085\ \(0\)\
\-\ size\\:\\ 0\\.04390504921307314\ \(0\)\
\-\ followed\\:\\ 0\\.04378755743636169\ \(0\)\
\-\ internal\\:\\ 0\\.043700228749249205\ \(0\)\
\-\ right\\:\\ 0\\.04299614598760143\ \(0\)\
\-\ out\\:\\ 0\\.04262208977827625\ \(0\)\
\-\ approximately\\:\\ 0\\.04137443213244067\ \(0\)\
\-\ medical\\:\\ 0\\.04121019687637402\ \(0\)\
\-\ clinical\\:\\ 0\\.04109432198717272\ \(0\)\
\-\ yo\\:\\ 0\\.04051010660043351\ \(0\)\
\-\ and\\:\\ 0\\.0401969157515885\ \(0\)\
\-\ for\\:\\ 0\\.03930671348121341\ \(0\)\
\-\ level\\:\\ 0\\.03916880664194768\ \(0\)\
\-\ abnormal\\:\\ 0\\.038956689358660174\ \(0\)\
\-\ she\\:\\ 0\\.0385993773342026\ \(0\)\
\-\ scan\\:\\ 0\\.03847051668723319\ \(0\)\
\-\ if\\:\\ 0\\.037675281446174755\ \(0\)\
\-\ surgery\\:\\ 0\\.03486223488290229\ \(0\)\
\-\ upper\\:\\ 0\\.03465099111362552\ \(0\)\
\-\ without\\:\\ 0\\.03420214206828561\ \(0\)\
\-\ woman\\:\\ 0\\.03377034518737197\ \(0\)\
\-\ small\\:\\ 0\\.03344810296701945\ \(0\)\
\-\ surgical\\:\\ 0\\.03151571871282035\ \(0\)\
\-\ after\\:\\ 0\\.031456307977246446\ \(0\)\
\-\ within\\:\\ 0\\.02986459675579197\ \(0\)\
\-\ disease\\:\\ 0\\.027218706247703065\ \(0\)\
\-\ normal\\:\\ 0\\.0264748827525132\ \(0\)\
\-\ as\\:\\ 0\\.026049656319897738\ \(0\)\
\-\ was\\:\\ 0\\.022598359738149335\ \(0\)\
\-\ on\\:\\ 0\\.019583640311113645\ \(0\)\
